Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic

[1]  Keshav R. Nayak,et al.  Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19 , 2022, Journal of the American College of Cardiology.

[2]  M. Lesiak,et al.  Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide , 2022, Viruses.

[3]  M. Mendelson,et al.  Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa , 2022, medRxiv.

[4]  C. Maslo,et al.  Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. , 2021, JAMA.

[5]  Massimo Siviglia,et al.  Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry , 2021, Atherosclerosis.

[6]  B. Gersh,et al.  International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 , 2021, Journal of the American College of Cardiology.

[7]  Brian C. Case,et al.  Initial Findings From the North American COVID-19 Myocardial Infarction Registry , 2021, Journal of the American College of Cardiology.

[8]  N. Curzen,et al.  Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction , 2020, Heart.

[9]  P. Libby,et al.  COVID-19 is, in the end, an endothelial disease , 2020, European heart journal.

[10]  J. Thachil,et al.  Coagulation abnormalities and thrombosis in patients with COVID-19 , 2020, The Lancet Haematology.

[11]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[12]  S. Farmer,et al.  Characteristics of ischaemic stroke associated with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[14]  J. M. Crawford,et al.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.

[15]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[16]  C. Siu,et al.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China , 2020, Circulation. Cardiovascular quality and outcomes.

[17]  Dong Men,et al.  Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients , 2020, medRxiv.

[18]  Michail I. Papafaklis,et al.  Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. , 2010, The Journal of invasive cardiology.

[19]  M. Miller.  Agency , 2010 .

[20]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[21]  B. Ibáñez,et al.  In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients , 2021, EuroIntervention.